Genotoxicity concerns for base and prime editors in hematopoietic stem cells

Genotoxicity concerns for base and prime editors in hematopoietic stem cells

    Nature Biotechnology

    (2023)Cite this article

    Subjects

    Although base and prime editors can be highly efficient in human hematopoietic stem cells, we find they can cause adverse cellular responses, including reduced engraftment and the generation of DNA double-strand breaks and genotoxic byproducts, albeit at a lower frequency than Cas9. We also find that base editors increase the genome-wide mutagenic load.

    This is a preview of subscription content, access via your institution

    Access options

    Access Nature and 54 other Nature Portfolio journals

    Get Nature+, our best-value online-access subscription

    $29.99 / 30 days

    cancel any time

    Subscribe to this journal

    Receive 12 print issues and online access

    $209.00 per year

    only $17.42 per issue

    Rent or buy this article

    Prices vary by article type

    from$1.95

    to$39.95

    Prices may be subject to local taxes which are calculated during checkout

    Fig. 1: Multiparameter comparison of Cas9, BE and PE for editing HSPCs in vitro and in xenografts.

    References

    1. Anzalone, A. V. et al. Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol. 38, 824–844 (2020). This review presents the different editing systems.

    2. Ferrari, S. et al. Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking. Nat Biotechnol. 38, 1298–1308 (2020). This paper reports the effect of Cas9-induced p53 activation on engraftment capacity of human HSPCs and graft clonality.

      Article 
      CAS 
      PubMed 
      PubMed Central 

      Google Scholar
       

    3. Park, S. H. et al. Comprehensive analysis and accurate quantification of unintended large gene modifications induced by CRISPR-Cas9 gene editing. Sci. Adv. 8, eabo7676 (2022). This paper reports a comprehensive characterization of the unintended editing outcomes occurring at CRISPR–Cas9 target sites in HSPCs.

      Article 
      CAS 
      PubMed 
      PubMed Central 

      Google Scholar
       

    4. Everette, K. A. et al. Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice. Nat. Biomed. Eng. 7, 616–628 (2023). This paper reports ex vivo prime editing in human HSPCs for the treatment of sickle cell disease.

      Article 
      CAS 
      PubMed 
      PubMed Central 

      Google Scholar
       

    5. Zeng, J. et al. Therapeutic base editing of human hematopoietic stem cells. Nat. Med. 26, 535–541 (2020). This paper reports ex vivo base editing in human HSPCs for the treatment of hemoglobinopathies.

      Article 
      CAS 
      PubMed 
      PubMed Central 

      Google Scholar
       

    Download references

    Additional information

    Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

    This is a summary of: Fiumara, M. et al. Genotoxic effects of base and prime editing in human hematopoietic stem cells. Nat. Biotechnol. https://doi.org/10.1038/s41587-023-01915-4 (2023).

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Genotoxicity concerns for base and prime editors in hematopoietic stem cells.
    Nat Biotechnol (2023). https://doi.org/10.1038/s41587-023-01916-3

    Download citation

    • Published:

    • DOI: https://doi.org/10.1038/s41587-023-01916-3

    Read More

    Leave a Reply

    Your email address will not be published. Required fields are marked *